세계의 리시노프릴 시장 보고서(2025년)

Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It works by reducing certain chemicals that tighten blood vessels, facilitating smoother blood flow and improving the heart's pumping efficiency. Lisinopril is prescribed for adults to treat congestive heart failure and to increase survival rates after a heart attack.

The main brands of lisinopril include Zestoretic, Prinivil, Zestril, among others. Zestoretic is a combination medication containing lisinopril, an ACE inhibitor, and hydrochlorothiazide, a thiazide diuretic. It is used to treat conditions such as hypertension, heart failure, heart attacks, strokes, diabetic kidney disease, among others. It is available in various forms such as tablets and liquid, and is prescribed to different populations including children and adults. These medications are used by various end-users such as hospitals, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The lisinopril market research report is one of a series of new reports from The Business Research Company that provides lisinopril market statistics, including lisinopril industry global market size, regional shares, competitors with a lisinopril market share, detailed lisinopril market segments, market trends, and opportunities, and any further data you may need to thrive in the lisinopril industry. This lisinopril market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lisinopril market size has grown strongly in recent years. It will grow from $1.76 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased accessibility, lifestyle shifts, increased screening programs, increased accessibility of generic lisinopril, and increased patient adherence.

The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising prevalence of hypertension and cardiovascular diseases, generic versions and cost-effectiveness, growing awareness and early diagnosis, growing demand for effective treatments, and aging population. Major trends in the forecast period include innovations in drug delivery, need for enhanced and patient-centric drug delivery approaches, demand for cost-effective solutions, demand for effective treatments for heart failure, and demand for effective treatments for diabetic kidney disease.

The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. healthcare systems by driving up the cost of Angiotensin-Converting Enzyme inhibitor(ACE) inhibitor medications and quality control testing equipment sourced from India and Puerto Rico, exacerbating hypertension treatment costs and creating medication access disparities. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the lisinopril market in the future. Cardiovascular diseases (CVDs) refer to a variety of conditions that affect the heart and blood vessels. The rising incidence of these diseases can be attributed to factors such as population growth, aging, risk factors, and the inadequate implementation of effective prevention and treatment strategies. Lisinopril aids in managing cardiovascular diseases primarily by lowering blood pressure and reducing the strain on the heart and kidneys. It works by inhibiting the production of angiotensin II, promoting blood vessel dilation, reducing blood volume, and protecting organs from damage. For example, in May 2024, the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, reported 5,302 deaths from ischemic heart diseases, a slight increase from 5,290 deaths in 2022. Therefore, the growing prevalence of cardiovascular diseases is fueling the growth of the lisinopril market.

The growing prevalence of hypertension is expected to boost the lisinopril market. Hypertension, or high blood pressure, is a condition where the force of blood against artery walls is consistently too high. Factors such as an unhealthy diet, sedentary lifestyle, aging population, and long-term stress contribute to the increasing prevalence of hypertension. Lisinopril effectively manages hypertension by blocking the formation of angiotensin II, leading to blood vessel relaxation, reduced blood volume, and lower blood pressure. For instance, the World Health Organization reported in March 2023 that around 1.28 billion adults aged 30-79 worldwide had hypertension. Therefore, the increasing prevalence of hypertension is driving the lisinopril market.

In January 2024, Sun Pharmaceutical Industries Limited, an Indian pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd for $347.73 million. This acquisition allows Sun Pharma to expand its portfolio by incorporating Taro's expertise in generic and specialty medicines, active pharmaceutical ingredients (APIs), and over-the-counter products. Taro Pharmaceutical Industries Ltd, a US-based company, offers lisinopril.

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences

North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lisinopril market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lisinopril market consists of sales of prinivil, qbrelis, zestoretic, zestril and apo-lisinopril. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lisinopril Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lisinopril market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lisinopril ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lisinopril market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
• 2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
• 3) By Dosage: Tablet; Liquid; Other Dosages
• 4) By Population Type: Children; Adults
• 5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
• 2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
• 3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
• 4) By Other Brands: International Brand Variants; Combination Drug Formulations
• Companies Mentioned: Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.; AstraZeneca Plc; Vitaris Inc.; Teva Pharmaceutical Industries Limited; Bausch Health Companies Inc.; Hetero Ltd.; Sun Pharmaceutical Industries Limited; Aurobindo Pharma Ltd.; Cipla Inc.; Hikma Pharmaceutical Plc; Apotex Inc.; Amneal Pharmaceutical Inc.; Lupin Ltd.; Zhejiang Huahai Pharmaceutical Co. Ltd.; Metrochem API Private Limited; Calyx Chemicals & Pharmaceuticals Limited; Farmhispania Group; Zydus Cadila Healthcare Ltd.; Qingdao Qingmei Biotech Co. Ltd.; LGM Pharma LLC; Amara Labs Pvt.; Sms Lifesciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lisinopril Market Characteristics

3. Lisinopril Market Trends And Strategies

4. Lisinopril Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lisinopril Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lisinopril PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lisinopril Market Growth Rate Analysis
• 5.4. Global Lisinopril Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lisinopril Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lisinopril Total Addressable Market (TAM)

6. Lisinopril Market Segmentation

• 6.1. Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zestoretic
• Prinivil
• Zestril
• Other Brands
• 6.2. Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypertension
• Heart Failure
• Heart Attack
• Strokes
• Diabetic Kidney Disease
• Other Diseases
• 6.3. Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Liquid
• Other Dosages
• 6.4. Global Lisinopril Market, Segmentation By Population Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• 6.5. Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.6. Global Lisinopril Market, Sub-Segmentation Of Zestoretic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Different Dosage Forms
• Generic Versions Of Zestoretic
• 6.7. Global Lisinopril Market, Sub-Segmentation Of Prinivil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Different Dosage Forms
• Generic Versions Of Prinivil
• 6.8. Global Lisinopril Market, Sub-Segmentation Of Zestril, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Different Dosage Forms
• Generic Versions Of Zestril
• 6.9. Global Lisinopril Market, Sub-Segmentation Of Other Brands, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• International Brand Variants
• Combination Drug Formulations

7. Lisinopril Market Regional And Country Analysis

• 7.1. Global Lisinopril Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lisinopril Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lisinopril Market

• 8.1. Asia-Pacific Lisinopril Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lisinopril Market

• 9.1. China Lisinopril Market Overview
• 9.2. China Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lisinopril Market

• 10.1. India Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lisinopril Market

• 11.1. Japan Lisinopril Market Overview
• 11.2. Japan Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lisinopril Market

• 12.1. Australia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lisinopril Market

• 13.1. Indonesia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lisinopril Market

• 14.1. South Korea Lisinopril Market Overview
• 14.2. South Korea Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lisinopril Market

• 15.1. Western Europe Lisinopril Market Overview
• 15.2. Western Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lisinopril Market

• 16.1. UK Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lisinopril Market

• 17.1. Germany Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lisinopril Market

• 18.1. France Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lisinopril Market

• 19.1. Italy Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lisinopril Market

• 20.1. Spain Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lisinopril Market

• 21.1. Eastern Europe Lisinopril Market Overview
• 21.2. Eastern Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lisinopril Market

• 22.1. Russia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lisinopril Market

• 23.1. North America Lisinopril Market Overview
• 23.2. North America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lisinopril Market

• 24.1. USA Lisinopril Market Overview
• 24.2. USA Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lisinopril Market

• 25.1. Canada Lisinopril Market Overview
• 25.2. Canada Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lisinopril Market

• 26.1. South America Lisinopril Market Overview
• 26.2. South America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lisinopril Market

• 27.1. Brazil Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lisinopril Market

• 28.1. Middle East Lisinopril Market Overview
• 28.2. Middle East Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lisinopril Market

• 29.1. Africa Lisinopril Market Overview
• 29.2. Africa Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lisinopril Market Competitive Landscape And Company Profiles

• 30.1. Lisinopril Market Competitive Landscape
• 30.2. Lisinopril Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Vitaris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lisinopril Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Limited
• 31.2. Bausch Health Companies Inc.
• 31.3. Hetero Ltd.
• 31.4. Sun Pharmaceutical Industries Limited
• 31.5. Aurobindo Pharma Ltd.
• 31.6. Cipla Inc.
• 31.7. Hikma Pharmaceutical Plc
• 31.8. Apotex Inc.
• 31.9. Amneal Pharmaceutical Inc.
• 31.10. Lupin Ltd.
• 31.11. Zhejiang Huahai Pharmaceutical Co. Ltd.
• 31.12. Metrochem API Private Limited
• 31.13. Calyx Chemicals & Pharmaceuticals Limited
• 31.14. Farmhispania Group
• 31.15. Zydus Cadila Healthcare Ltd.

32. Global Lisinopril Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lisinopril Market

34. Recent Developments In The Lisinopril Market

35. Lisinopril Market High Potential Countries, Segments and Strategies

• 35.1 Lisinopril Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lisinopril Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lisinopril Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer